Supplement
Zeaxanthins clinical trials
Also written zeaxanthin.
- studies test it
- 15
- open now
- 1
- in phase 3
- 2
- first study started
- 2006
Keep track of what changes. Save the Zeaxanthins studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 1
- No phase
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 14
University of Georgia (2) · Mansoura University (1) · Insel Gruppe AG, University Hospital Bern (1) · Queen's University, Belfast (1) · Johns Hopkins University (1) · Maastricht University Medical Center (1) · Affordance (1) · National Eye Institute (NEI) (1)
Often tested with
Tested in the same studies.
Lutein (13) · Fish Oils (4) · Ascorbic Acid (4) · Alpha-Tocopherol (4) · Cholecalciferol (4) · Zinc (4) · Copper (4) · Selenium (4)
Studies
Open first, then newest update. How each study uses Zeaxanthins is read from its arms, and is right about nine times in ten.
Testing it · 15
- Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic CancerRecruitingPhase 1Valley Health SystemNCT05232409Written as Zeaxanthin
- Clinical and Radiographic Assessment of PRF Versus Lutein PlacementCompletedNot applicableMansoura UniversityNCT06358352Written as Lutein / Zeaxanthin
- FLIO and the Influence of Oral Lutein Supplementation on Macular PigmentCompletedPhase 4Insel Gruppe AG, University Hospital BernNCT04761341Written as NUTROF TOTAL
- Macular Pigment and Glare DisabilityCompletedNot applicableUniversity of GeorgiaNCT00909090Written as 12 mg Lutein + Zeaxanthin
- Investigation of the Genetic and Environmental Determinants of MP Including Response to SupplementationCompletedNot applicableQueen's University, BelfastNCT01778231Written as Nutrof Total
- Lutein and Alzheimer's Disease StudyTerminatedPhase 2Oregon Health and Science UniversityNCT00596024Written as lutein/zeaxanthin
- The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With AlbinismCompletedNot applicableJohns Hopkins UniversityNCT02200263Written as Lutein plus Zeaxanthin
- The Effect of Eggs and Egg Products on Macular PigmentCompletedNot applicableMaastricht University Medical CenterNCT00527553Written as zeaxanthin
- Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine SupplementationCompletedNot applicableAffordanceNCT01404845Written as Nutrof Total
- The Effects of a Zeaxanthin Intervention on Visuomotor FunctionCompletedNot applicableUniversity of GeorgiaNCT02017418Written as zeaxanthin
- Age-Related Eye Disease Study 2 (AREDS2)CompletedPhase 3National Eye Institute (NEI)NCT00345176Written as Lutein/zeaxanthin
- Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular DegenerationCompletedNot applicablePeking UniversityNCT01528605Written as lutein plus zeaxanthin
- Lutein Influence on Macula of Persons Issued From Amd ParentsCompletedPhase 3University Hospital, BordeauxNCT01269697Written as Nutrof Total
- Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)CompletedNot applicableUniversity of JenaNCT01648660Written as Lutein/ Zeaxanthin + Omega- 3- Fatty Acids
- The Zeaxanthin and Visual Function StudyCompletedNot applicableChrysantis, Inc.NCT00564902Written as Lutein and Zeaxanthin
As the comparator · 2 — what is tested is compared with Zeaxanthins
Codes
What other systems call Zeaxanthins · ClinicalTrials.gg INT008984
- MeSH (NLM) D065146ZeaxanthinsOne source Wikidata
- UNII (FDA) CV0IB81OROZEAXANTHINConfirmed FDA, Wikidata
- RxNorm 39918Confirmed FDA, Wikidata
- Wikidata Q169337zeaxanthinConfirmed FDA, Wikidata
- NCI Thesaurus C68310ZeaxanthinOne source FDA
- DrugBank DB11176One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D065146 | Zeaxanthins | One source Wikidata |
| UNII (FDA) | CV0IB81ORO | ZEAXANTHIN | Confirmed FDA, Wikidata |
| RxNorm | 39918 | — | Confirmed FDA, Wikidata |
| Wikidata | Q169337 | zeaxanthin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C68310 | Zeaxanthin | One source FDA |
| DrugBank | DB11176 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.